Board Meeting Details
- Date: Friday, 30th October, 2026
- Time: 11:45 am to 1:15 pm
- Location: Registered office
Financial Results Approval
The Board of Directors considered, approved and took on record the Unaudited Financial Results (Standalone & Consolidated) for the quarter & half year ended 30th September, 2026.
Auditor Review
B S R & Co. LLP, Chartered Accountants, issued Limited Review Reports with unmodified opinion for both standalone and consolidated financial results.
Consolidated Financial Results (INR in Lakhs)
Income Statement
Quarter Ended September 30, 2026:
- Revenue from operations: ₹105,168.19
- Other income: ₹4,463.02
- Total income: ₹109,631.21
- Total expenses: ₹98,882.47
- Profit before tax: ₹10,748.74
- Total tax expense: ₹1,576.01
- Net profit for the period: ₹9,172.73
- Other comprehensive income/(loss): ₹(478.69)
- Total comprehensive income: ₹8,694.04
Half Year Ended September 30, 2026:
- Revenue from operations: ₹212,545.00
- Other income: ₹7,915.59
- Total income: ₹220,460.59
- Total expenses: ₹197,869.34
- Profit before tax: ₹22,591.25
- Total tax expense: ₹4,616.87
- Net profit for the period: ₹17,974.38
- Other comprehensive income: ₹1,502.19
- Total comprehensive income: ₹19,476.57
Comparative Figures
Quarter Ended September 30, 2025:
- Revenue from operations: ₹92,911.27
- Net profit: ₹7,435.62
Half Year Ended September 30, 2025:
- Revenue from operations: ₹191,392.73
- Net profit: ₹21,715.36
Earnings Per Share (Face value ₹10 each)
Quarter Ended September 30, 2026:
- Basic EPS: ₹10.17
- Diluted EPS: ₹10.17
Half Year Ended September 30, 2026:
- Basic EPS: ₹19.93
- Diluted EPS: ₹19.93
Segment Information (Consolidated)
Quarter Ended September 30, 2026:
- Agrochemicals revenue: ₹83,972.67
- Non-agrochemicals revenue: ₹21,195.52
- Agrochemicals segment result: ₹6,885.15
- Non-agrochemicals segment result: ₹3,735.80
Half Year Ended September 30, 2026:
- Agrochemicals revenue: ₹175,458.49
- Non-agrochemicals revenue: ₹37,086.51
Standalone Financial Results (INR in Lakhs)
Quarter Ended September 30, 2026:
- Revenue from operations: ₹74,242.79
- Other income: ₹4,153.47
- Total income: ₹78,396.26
- Total expenses: ₹70,749.33
- Profit before tax: ₹7,646.93
- Total tax expense: ₹1,498.61
- Net profit for the period: ₹6,148.32
Half Year Ended September 30, 2026:
- Revenue from operations: ₹171,131.39
- Other income: ₹14,850.66
- Total income: ₹185,982.05
- Total expenses: ₹160,637.39
- Profit before tax: ₹25,344.66
- Total tax expense: ₹5,137.45
- Net profit for the period: ₹20,207.21
Standalone EPS (Face value ₹10 each)
Quarter Ended September 30, 2026:
- Basic EPS: ₹6.82
- Diluted EPS: ₹6.82
Half Year Ended September 30, 2026:
- Basic EPS: ₹22.40
- Diluted EPS: ₹22.40
Assets and Liabilities Position (Consolidated)
As at September 30, 2026:
- Total assets: ₹565,913.06 lakhs
- Total equity: ₹325,048.85 lakhs
- Non-current liabilities: ₹27,190.08 lakhs
- Current liabilities: ₹213,674.13 lakhs
Comparative (March 31, 2026):
- Total assets: ₹578,030.00 lakhs
- Total equity: ₹313,703.57 lakhs
Cash Flow Statement (Consolidated)
Half Year Ended September 30, 2026:
- Net cash from operating activities: ₹56,420.32
- Net cash used in investing activities: ₹(40,576.48)
- Net cash used in financing activities: ₹(8,814.52)
- Net increase in cash: ₹8,518.56
- Cash and cash equivalents at end: ₹29,901.15
Subsidiary Information
The consolidated results include 36 subsidiaries (including 8 step-down subsidiaries). Key subsidiary financials reviewed:
- Eight subsidiaries with total assets of ₹75,762 lakhs and total revenues of ₹33,304 lakhs for Q2 FY27
- One foreign subsidiary with total assets of ₹57,768 lakhs and total revenues of ₹30,992 lakhs for Q2 FY27
- Nineteen subsidiaries considered not material to the Group
Dividend Information
- Dividend paid on equity shares during H1 FY27: ₹8,118.06 lakhs
Key Notes
1. Financial results prepared in accordance with Ind AS 34 (Interim Financial Reporting)
2. Agrochemicals segment is seasonal and quarterly figures may not represent full year performance
3. Other expenses include gain on fair valuation of investments of ₹(607.55) lakhs for H1 FY27
4. Standalone other income includes dividend received from subsidiary of ₹7,542.24 lakhs for H1 FY27